BeOne Medicines AG - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US07725L1026
236,00 € ↑2,00 (0,85%)
2026-06-04
DEL PRIS
SecurityDE:49BA / BeOne Medicines AG - Depositary Receipt (Common Stock)
InstitutionNorthern Trust Corp
Latest Disclosed Ownership36,132 shares
Latest Disclosed Value $ 10,730,120
Northern Trust Corp reports 11.07% decrease in ownership of 49BA / BeOne Medicines AG - Depositary Receipt (Common Stock)

On May 14, 2026 - Northern Trust Corp filed a 13F-HR form disclosing ownership of 36,132 shares of BeOne Medicines AG - Depositary Receipt (Common Stock) (DE:49BA) valued at $8,960,736 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 40,629 shares of BeOne Medicines AG - Depositary Receipt (Common Stock). This represents a change in shares of -11.07% during the quarter. The current value of the position is $8,527,152 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F BEONE MEDICINES SPONSORED ADS 07725L102 36,132 -4,497 -11.07 10,730 -13.07 0.0003
2026-02-17 2025-12-31 13F BEONE MEDICINES SPONSORED ADS 07725L102 40,629 17,695 77.16 12,343 57.98 0.0003
2025-11-14 2025-09-30 13F BEONE MEDICINES SPONSORED ADS 07725L102 22,934 6,340 38.21 7,814 94.55 0.0010
2025-08-13 2025-06-30 13F BEONE MEDICINES SPONSORED ADS 07725L102 16,594 -702 -4.06 4,017 -14.68 0.0006
2025-05-13 2025-03-31 13F BEIGENE SPONSORED ADS 07725L102 17,296 -1,574 -8.34 4,707 35.06 0.0007
2025-02-14 2024-12-31 13F BEIGENE SPONSORED ADR 07725L102 18,870 6,496 52.50 3,485 25.45 0.0005
2024-11-13 2024-09-30 13F BEIGENE COM 07725L102 12,374 614 5.22 2,778 65.65 0.0005
2024-08-14 2024-06-30 13F BEIGENE COM 07725L102 11,760 679 6.13 1,678 -3.18 0.0003
2024-05-14 2024-03-31 13F BEIGENE COM 07725L102 11,081 1,853 20.08 1,733 4.09 0.0003
2024-02-13 2023-12-31 13F BEIGENE COM 07725L102 9,228 524 6.02 1,664 6.33 0.0003
2023-11-13 2023-09-30 13F BEIGENE COM 07725L102 8,704 -462 -5.04 1,566 -4.22 0.0003
2023-08-11 2023-06-30 13F BEIGENE COM 07725L102 9,166 232 2.60 1,634 -15.12 0.0003
2023-05-15 2023-03-31 13F BEIGENE COM 07725L102 8,934 -25,502 -74.06 1,926 -74.58 0.0004
2023-02-13 2022-12-31 13F BEIGENE COM 07725L102 34,436 -87,309 -71.71 7,574 -53.86 0.0016
2022-11-14 2022-09-30 13F BEIGENE COM 07725L102 121,745 6,711 5.83 16,414 -11.84 0.0037
2022-08-12 2022-06-30 13F BEIGENE COM 07725L102 115,034 8,231 7.71 18,618 -7.57 0.0040
2022-05-13 2022-03-31 13F BEIGENE COM 07725L102 106,803 -7,421 -6.50 20,143 -34.91 0.0035
2022-02-08 2021-12-31 13F BEIGENE SPONSORED ADR 07725L102 114,224 -8,456 -6.89 30,946 -30.51 0.0051
2021-11-15 2021-09-30 13F BEIGENE SPONSORED ADR 07725L102 122,680 -76,320 -38.35 44,532 -34.79 0.0079
2021-08-13 2021-06-30 13F BEIGENE SPONSORED ADR 07725L102 199,000 -24,742 -11.06 68,295 -12.31 0.0120
2021-05-12 2021-03-31 13F BEIGENE SPONSORED ADR 07725L102 223,742 -3,018 -1.33 77,880 32.92 0.0145
2021-02-11 2020-12-31 13F BEIGENE SPONSORED ADR 07725L102 226,760 -102,261 -31.08 58,593 -37.83 0.0114
2020-11-16 2020-09-30 13F BEIGENE SPONSORED ADR 07725L102 329,021 17,375 5.58 94,244 60.51 0.0207
2020-08-14 2020-06-30 13F BEIGENE COM 07725L102 311,646 326 0.10 58,714 53.19 0.0139
2020-05-14 2020-03-31 13F BEIGENE SPONSORED ADR 07725L102 311,320 -296,854 -48.81 38,328 -61.98 0.0110
2020-02-14 2019-12-31 13F BEIGENE SPONSORED ADR 07725L102 608,174 9,287 1.55 100,811 37.46 0.0226
2019-11-13 2019-09-30 13F BEIGENE COM 07725L102 598,887 3,973 0.67 73,339 -0.54 0.0176
2019-08-13 2019-06-30 13F BEIGENE SPONSORED ADR 07725L102 594,914 28,569 5.04 73,739 -1.36 0.0175
2019-05-13 2019-03-31 13F BEIGENE SPONSORED ADR 07725L102 566,345 -78 -0.01 74,757 -5.90 0.0185
2019-02-12 2018-12-31 13F BEIGENE SPONSORED ADR 07725L102 566,423 563,865 22,043.20 79,446 17,955.91 0.0223
2018-11-14 2018-09-30 13F BEIGENE COM 07725L102 2,558 308 13.69 440 27.17 0.0001
2018-09-18 2018-06-30 13F/A-1 BEIGENE COM 07725L102 2,250 453 25.21 346 14.57 0.0001
2018-08-14 2018-06-30 13F BEIGENE COM 07725L102 2,250 453 346
2018-05-09 2018-03-31 13F BEIGENE COM 07725L102 1,797 1,797 302 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.